EGFR and head and neck squamous cell carcinoma: Patient-derived HNSCC organoids have emerged as a valuable 3D model for evaluating EGFR-targeted photodynamic therapy (PDT) accurately reflecting varying EGFR expression levels correlating to PDT responses (Driehuis et al., 2019[4]).